Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

NCT00003414 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Lymphoma

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: recombinant interferon gamma
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: cyclosporine
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]